APAC Human Fibrin Glue (HFG) Market - Industry Trends and Forecast to 2029
- Published Date: 2022-11-21
- Report ID: 144430
- Pages: 200
-
Format:
Short Description
Asia-Pacific Human Fibrin Glue Market, By Form (Liquid, Patch, Others), Application (Cardiac Surgery, Pulmonary Surgery, Burn Bleeding, Vascular Surgeries, Orthopedic Surgeries, Lacerations of liver and Spleen, Neurosurgery, Plastic Surgery, General Surgery, Wound Management, others), Distribution Channel (Direct Tender and Retail Sales), End User (Hospitals, Ambulatory Care Centers, Specialty Clinics, Others), Country (Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Rest of Asia-Pacific) Industry Trends and Forecast to 2029
Market Definition:
Human fibrin glue is indicated as an adjunct to haemostasis for mild to moderate bleeding in adults undergoing surgery when control of bleeding by standard surgical methods are not possible. They are used in wound healing and various surgery for haemostasis and wound management.
The demand for human fibrin glue is increasing increased in the market with the presence of major market players and rising demand of human fibrin glue during surgeries. Also due to introduction of innovative products, increasing in technological products and rising disposable income the market is growing. The market will grow in forecasted period with the rise in launch of new products by major market players.
Market Segmentation:
Asia-Pacific human fibrin glue market is categorized into four notable segments, based on package form, application, end user and distribution channel.
On the basis of package form, the human fibrin glue market is segmented into liquid, patch, and others
On the basis of application, the human fibrin glue market is segmented into cardiac surgery, pulmonary surgery, burn bleeding, vascular surgeries, orthopedic surgeries, lacerations of liver and spleen, neurosurgery, plastic surgery, general surgery, wound management, and others
On the basis of end user, the human fibrin glue market is segmented into hospitals, ambulatory care centre, speciality clinics, and others
On the basis of distribution channel, the human fibrin glue market is segmented into direct tender and retail sales
Market Players
The key market players for Asia-Pacific human fibrin glue market are listed below:
Johnson & Johnson Services, Inc.
Baxter
CSL Limited
Corza Health
Shanghai RAAS
Hualan Biological Engineering, Inc
Marquee Biosurgical
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PACKAGE FORM LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.10 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
6 REGULATORY ANALYSIS
6.1.1 REGULATION IN U.S.
6.1.2 REGULATION IN EUROPE
6.1.3 REGULATION IN AUSTRALIA
6.1.4 REGULATION IN CANADA
6.1.5 REGULATION IN CHINA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASING SURGICAL PROCEDURES
7.1.3 ADVANTAGES OF HUMAN FIBRIN GLUE
7.1.4 INCREASE IN THE GERIATRIC POPULATION
7.1.5 SUPERIORITY OF FIBRIN SEALANTS, OVER LIMITATIONS OF CONVENTIONAL METHODS
7.2 RESTRAINTS
7.2.1 STRINGENT RULES & REGULATORY
7.2.2 HIGH COST OF PRODUCTS
7.2.3 RISK OF VIRAL INFECTIONS
7.3 OPPORTUNITIES
7.3.1 INCREASE IN PREVALENCE OF CHRONIC DISORDERS
7.3.2 RISE IN MINIMALLY INVASIVE SURGERIES
7.3.3 RISING PLASTIC SURGERIES
7.4 CHALLENGES
7.4.1 COMPLICATION RELATED TO USE OF HUMAN FIBRIN GLUE
7.4.2 LACK OF SKILLED PROFESSIONALS
7.4.3 DECREASED SURGICAL PROCEDURES DUE TO COVID-19
8 IMPACT OF COVID-19 ON ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON SUPPLY CHAIN
8.3 IMPACT ON DEMAND
8.4 CONCLUSION
9 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM
9.1 OVERVIEW
9.2 LIQUID
9.2.1 1-2 ML
9.2.2 7-10 ML
9.2.3 3-4 ML
9.2.4 5-6 ML
9.3 PATCH
9.4 OTHERS
10 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 SPECIALTY CLINICS
10.4 AMBULATORY CARE CENTER
10.5 OTHERS
11 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 WOUND MANAGEMENT
12.3 BURN BLEEDING
12.4 PLASTIC SURGERY
12.5 GENERAL SURGERY
12.6 VASCULAR SURGERIES
12.7 LACERATIONS OF LIVER AND SPLEEN
12.8 CARDIAC SURGERY
12.9 PULMONARY SURGERY
12.10 ORTHOPEDIC SURGERIES
12.11 NEUROSURGERY
12.12 OTHERS
13 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION
13.1 ASIA-PACIFIC
13.1.1 CHINA
13.1.2 INDIA
13.1.3 JAPAN
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 THAILAND
13.1.7 MALAYSIA
13.1.8 SINGAPORE
13.1.9 INDONESIA
13.1.10 REST OF ASIA-PACIFIC
14 ASIA-PACIFIC HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 CSL LIMITED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 JOHNSON & JOHNSON SERVICES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 BAXTER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 HUALAN BIOLOGICAL ENGINEERING, ING
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 SHANGHAI RAAS
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 CORZA HEALTH
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 MARQUEE BIOSURGICAL
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
